Targeting bacterial quorum sensing shows promise in improving intestinal barrier function following burn‑site infection

Burn‑site infections, commonly due to Pseudomonas aeruginosa, have been associated with deranged intestinal integrity, allowing bacteria and their products to translocate from the gut to the circulatory system. The P. aeruginosa quorum sensing (QS) transcription factor MvfR (PqsR) controls the expre...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Molecular medicine reports 2019-05, Vol.19 (5), p.4057-4066
Hauptverfasser: Adiliaghdam, Fatemeh, Almpani, Marianna, Gharedaghi, Mohammad Hadi, Najibi, Mehran, Hodin, Richard A, Rahme, Laurence G
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 4066
container_issue 5
container_start_page 4057
container_title Molecular medicine reports
container_volume 19
creator Adiliaghdam, Fatemeh
Almpani, Marianna
Gharedaghi, Mohammad Hadi
Najibi, Mehran
Hodin, Richard A
Rahme, Laurence G
description Burn‑site infections, commonly due to Pseudomonas aeruginosa, have been associated with deranged intestinal integrity, allowing bacteria and their products to translocate from the gut to the circulatory system. The P. aeruginosa quorum sensing (QS) transcription factor MvfR (PqsR) controls the expression of numerous virulence factors, and the synthesis of several toxic products. However, the role of QS in intestinal integrity alterations, to the best of our knowledge, has not been previously investigated. Using a proven anti‑MvfR, anti‑virulence agent, the in vivo results of the present study revealed that inhibition of MvfR function significantly decreased Fluorescein Isothiocyanate‑Dextran (FITC‑Dextran) flow from the intestine to the systemic circulation, diminished bacterial translocation from the intestine to mesenteric lymph nodes (MLNs), and improved tight junction integrity in thermally injured and infected mice. In addition, the MvfR antagonist administration alleviates the intestinal inflammation, as demonstrated by reduced ileal TNF‑α and fecal lipocalin‑2 concentrations. In addition, it is associated with lower levels of circulating endotoxin and decreased P. aeruginosa dissemination from the burn wound to the ileum. Collectively, these results hold great promise that the inhibition of this QS system mitigates gut hyperpermeability by attenuating the derangement of morphological and immune aspects of the intestinal barrier, suggesting that MvfR function is crucial in the deterioration of intestinal integrity following P. aeruginosa burn‑site infection. Therefore, an anti‑virulence approach targeting MvfR, could potentially offer a novel therapeutic approach against multi‑drug resistant P. aeruginosa infections following thermal injuries. Since this approach is targeting virulence pathways that are non‑essential for growth or viability, our strategy is hypothesized to minimize the development of bacterial resistance, and preserve the beneficial enteric microbes, while improving intestinal integrity that is deranged as a result of burn and infection.
doi_str_mv 10.3892/mmr.2019.10071
format Article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6472113</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A585448562</galeid><sourcerecordid>A585448562</sourcerecordid><originalsourceid>FETCH-LOGICAL-c485t-bfe75d4b8879d3eadeb045934b00065a9ea0b92bfdc866aef24f568586323a943</originalsourceid><addsrcrecordid>eNptUstqFTEYDqLY2nbrUgZcn9NcZ5KNUIpVoeCmrkOS-XOaMpOcJjMt3fkKvqJP0szxWCuULHL5LuRLPoTeE7xmUtHTccxriolaE4w78godkk6RFcOYv96vqVLdAXpXyg3GraBCvUUHDEvVSsIO0cOVyRuYQtw01rgJcjBDczunPI9NgVgWoFyn-9JscxpDgSbEJox1c7dAIU5QqrqKrMk5QG78HN0UUmx8GoZ0v3Oec_z981cJ0yL3sMOP0RtvhgIn-_kI_bj4fHX-dXX5_cu387PLleNSTCvroRM9t1J2qmdgerCYC8W4xUseo8Bgq6j1vZNta8BT7kUrhWwZZUZxdoQ-_fHdznaE3kGcshn0NofR5AedTND_IzFc60260y3vKCGsGnzcG-R0O9e4-ibVQPXOmlYClbRT9B9rYwbQNWWqZq6-mNNnQgpew7QLa_0Cq44exuBSBB_q-UsCl1MpGfzTxQnWSwN0bYBeGqB3DaiCD8_jPtH_fjl7BMxDsLc</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2211282792</pqid></control><display><type>article</type><title>Targeting bacterial quorum sensing shows promise in improving intestinal barrier function following burn‑site infection</title><source>Spandidos Publications Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Adiliaghdam, Fatemeh ; Almpani, Marianna ; Gharedaghi, Mohammad Hadi ; Najibi, Mehran ; Hodin, Richard A ; Rahme, Laurence G</creator><creatorcontrib>Adiliaghdam, Fatemeh ; Almpani, Marianna ; Gharedaghi, Mohammad Hadi ; Najibi, Mehran ; Hodin, Richard A ; Rahme, Laurence G</creatorcontrib><description>Burn‑site infections, commonly due to Pseudomonas aeruginosa, have been associated with deranged intestinal integrity, allowing bacteria and their products to translocate from the gut to the circulatory system. The P. aeruginosa quorum sensing (QS) transcription factor MvfR (PqsR) controls the expression of numerous virulence factors, and the synthesis of several toxic products. However, the role of QS in intestinal integrity alterations, to the best of our knowledge, has not been previously investigated. Using a proven anti‑MvfR, anti‑virulence agent, the in vivo results of the present study revealed that inhibition of MvfR function significantly decreased Fluorescein Isothiocyanate‑Dextran (FITC‑Dextran) flow from the intestine to the systemic circulation, diminished bacterial translocation from the intestine to mesenteric lymph nodes (MLNs), and improved tight junction integrity in thermally injured and infected mice. In addition, the MvfR antagonist administration alleviates the intestinal inflammation, as demonstrated by reduced ileal TNF‑α and fecal lipocalin‑2 concentrations. In addition, it is associated with lower levels of circulating endotoxin and decreased P. aeruginosa dissemination from the burn wound to the ileum. Collectively, these results hold great promise that the inhibition of this QS system mitigates gut hyperpermeability by attenuating the derangement of morphological and immune aspects of the intestinal barrier, suggesting that MvfR function is crucial in the deterioration of intestinal integrity following P. aeruginosa burn‑site infection. Therefore, an anti‑virulence approach targeting MvfR, could potentially offer a novel therapeutic approach against multi‑drug resistant P. aeruginosa infections following thermal injuries. Since this approach is targeting virulence pathways that are non‑essential for growth or viability, our strategy is hypothesized to minimize the development of bacterial resistance, and preserve the beneficial enteric microbes, while improving intestinal integrity that is deranged as a result of burn and infection.</description><identifier>ISSN: 1791-2997</identifier><identifier>EISSN: 1791-3004</identifier><identifier>DOI: 10.3892/mmr.2019.10071</identifier><identifier>PMID: 30896813</identifier><language>eng</language><publisher>Greece: Spandidos Publications</publisher><subject>Antibiotics ; Backup software ; Bacteria ; Burns ; Circulatory system ; Cytokines ; Dextran ; Dextrans ; Digestive system ; Drug resistance ; Fluorescein ; Fluorescein isothiocyanate ; Gastrointestinal tract ; Ileum ; Infection ; Infections ; Intestine ; Laboratories ; Lipocalin ; Lymph nodes ; Lymphocytes ; Microorganisms ; Multidrug resistance ; Novels ; Permeability ; Polysaccharides ; Pseudomonas aeruginosa ; Quorum sensing ; Regulation ; Sepsis ; T cells ; Therapeutics ; Tumor necrosis factor-TNF ; Tumor necrosis factor-α ; Virulence factors</subject><ispartof>Molecular medicine reports, 2019-05, Vol.19 (5), p.4057-4066</ispartof><rights>COPYRIGHT 2019 Spandidos Publications</rights><rights>Copyright Spandidos Publications UK Ltd. 2019</rights><rights>Copyright: © Adiliaghdam et al. 2019</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c485t-bfe75d4b8879d3eadeb045934b00065a9ea0b92bfdc866aef24f568586323a943</citedby><cites>FETCH-LOGICAL-c485t-bfe75d4b8879d3eadeb045934b00065a9ea0b92bfdc866aef24f568586323a943</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30896813$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Adiliaghdam, Fatemeh</creatorcontrib><creatorcontrib>Almpani, Marianna</creatorcontrib><creatorcontrib>Gharedaghi, Mohammad Hadi</creatorcontrib><creatorcontrib>Najibi, Mehran</creatorcontrib><creatorcontrib>Hodin, Richard A</creatorcontrib><creatorcontrib>Rahme, Laurence G</creatorcontrib><title>Targeting bacterial quorum sensing shows promise in improving intestinal barrier function following burn‑site infection</title><title>Molecular medicine reports</title><addtitle>Mol Med Rep</addtitle><description>Burn‑site infections, commonly due to Pseudomonas aeruginosa, have been associated with deranged intestinal integrity, allowing bacteria and their products to translocate from the gut to the circulatory system. The P. aeruginosa quorum sensing (QS) transcription factor MvfR (PqsR) controls the expression of numerous virulence factors, and the synthesis of several toxic products. However, the role of QS in intestinal integrity alterations, to the best of our knowledge, has not been previously investigated. Using a proven anti‑MvfR, anti‑virulence agent, the in vivo results of the present study revealed that inhibition of MvfR function significantly decreased Fluorescein Isothiocyanate‑Dextran (FITC‑Dextran) flow from the intestine to the systemic circulation, diminished bacterial translocation from the intestine to mesenteric lymph nodes (MLNs), and improved tight junction integrity in thermally injured and infected mice. In addition, the MvfR antagonist administration alleviates the intestinal inflammation, as demonstrated by reduced ileal TNF‑α and fecal lipocalin‑2 concentrations. In addition, it is associated with lower levels of circulating endotoxin and decreased P. aeruginosa dissemination from the burn wound to the ileum. Collectively, these results hold great promise that the inhibition of this QS system mitigates gut hyperpermeability by attenuating the derangement of morphological and immune aspects of the intestinal barrier, suggesting that MvfR function is crucial in the deterioration of intestinal integrity following P. aeruginosa burn‑site infection. Therefore, an anti‑virulence approach targeting MvfR, could potentially offer a novel therapeutic approach against multi‑drug resistant P. aeruginosa infections following thermal injuries. Since this approach is targeting virulence pathways that are non‑essential for growth or viability, our strategy is hypothesized to minimize the development of bacterial resistance, and preserve the beneficial enteric microbes, while improving intestinal integrity that is deranged as a result of burn and infection.</description><subject>Antibiotics</subject><subject>Backup software</subject><subject>Bacteria</subject><subject>Burns</subject><subject>Circulatory system</subject><subject>Cytokines</subject><subject>Dextran</subject><subject>Dextrans</subject><subject>Digestive system</subject><subject>Drug resistance</subject><subject>Fluorescein</subject><subject>Fluorescein isothiocyanate</subject><subject>Gastrointestinal tract</subject><subject>Ileum</subject><subject>Infection</subject><subject>Infections</subject><subject>Intestine</subject><subject>Laboratories</subject><subject>Lipocalin</subject><subject>Lymph nodes</subject><subject>Lymphocytes</subject><subject>Microorganisms</subject><subject>Multidrug resistance</subject><subject>Novels</subject><subject>Permeability</subject><subject>Polysaccharides</subject><subject>Pseudomonas aeruginosa</subject><subject>Quorum sensing</subject><subject>Regulation</subject><subject>Sepsis</subject><subject>T cells</subject><subject>Therapeutics</subject><subject>Tumor necrosis factor-TNF</subject><subject>Tumor necrosis factor-α</subject><subject>Virulence factors</subject><issn>1791-2997</issn><issn>1791-3004</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNptUstqFTEYDqLY2nbrUgZcn9NcZ5KNUIpVoeCmrkOS-XOaMpOcJjMt3fkKvqJP0szxWCuULHL5LuRLPoTeE7xmUtHTccxriolaE4w78godkk6RFcOYv96vqVLdAXpXyg3GraBCvUUHDEvVSsIO0cOVyRuYQtw01rgJcjBDczunPI9NgVgWoFyn-9JscxpDgSbEJox1c7dAIU5QqrqKrMk5QG78HN0UUmx8GoZ0v3Oec_z981cJ0yL3sMOP0RtvhgIn-_kI_bj4fHX-dXX5_cu387PLleNSTCvroRM9t1J2qmdgerCYC8W4xUseo8Bgq6j1vZNta8BT7kUrhWwZZUZxdoQ-_fHdznaE3kGcshn0NofR5AedTND_IzFc60260y3vKCGsGnzcG-R0O9e4-ibVQPXOmlYClbRT9B9rYwbQNWWqZq6-mNNnQgpew7QLa_0Cq44exuBSBB_q-UsCl1MpGfzTxQnWSwN0bYBeGqB3DaiCD8_jPtH_fjl7BMxDsLc</recordid><startdate>20190501</startdate><enddate>20190501</enddate><creator>Adiliaghdam, Fatemeh</creator><creator>Almpani, Marianna</creator><creator>Gharedaghi, Mohammad Hadi</creator><creator>Najibi, Mehran</creator><creator>Hodin, Richard A</creator><creator>Rahme, Laurence G</creator><general>Spandidos Publications</general><general>Spandidos Publications UK Ltd</general><general>D.A. Spandidos</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>5PM</scope></search><sort><creationdate>20190501</creationdate><title>Targeting bacterial quorum sensing shows promise in improving intestinal barrier function following burn‑site infection</title><author>Adiliaghdam, Fatemeh ; Almpani, Marianna ; Gharedaghi, Mohammad Hadi ; Najibi, Mehran ; Hodin, Richard A ; Rahme, Laurence G</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c485t-bfe75d4b8879d3eadeb045934b00065a9ea0b92bfdc866aef24f568586323a943</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Antibiotics</topic><topic>Backup software</topic><topic>Bacteria</topic><topic>Burns</topic><topic>Circulatory system</topic><topic>Cytokines</topic><topic>Dextran</topic><topic>Dextrans</topic><topic>Digestive system</topic><topic>Drug resistance</topic><topic>Fluorescein</topic><topic>Fluorescein isothiocyanate</topic><topic>Gastrointestinal tract</topic><topic>Ileum</topic><topic>Infection</topic><topic>Infections</topic><topic>Intestine</topic><topic>Laboratories</topic><topic>Lipocalin</topic><topic>Lymph nodes</topic><topic>Lymphocytes</topic><topic>Microorganisms</topic><topic>Multidrug resistance</topic><topic>Novels</topic><topic>Permeability</topic><topic>Polysaccharides</topic><topic>Pseudomonas aeruginosa</topic><topic>Quorum sensing</topic><topic>Regulation</topic><topic>Sepsis</topic><topic>T cells</topic><topic>Therapeutics</topic><topic>Tumor necrosis factor-TNF</topic><topic>Tumor necrosis factor-α</topic><topic>Virulence factors</topic><toplevel>online_resources</toplevel><creatorcontrib>Adiliaghdam, Fatemeh</creatorcontrib><creatorcontrib>Almpani, Marianna</creatorcontrib><creatorcontrib>Gharedaghi, Mohammad Hadi</creatorcontrib><creatorcontrib>Najibi, Mehran</creatorcontrib><creatorcontrib>Hodin, Richard A</creatorcontrib><creatorcontrib>Rahme, Laurence G</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Molecular medicine reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Adiliaghdam, Fatemeh</au><au>Almpani, Marianna</au><au>Gharedaghi, Mohammad Hadi</au><au>Najibi, Mehran</au><au>Hodin, Richard A</au><au>Rahme, Laurence G</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Targeting bacterial quorum sensing shows promise in improving intestinal barrier function following burn‑site infection</atitle><jtitle>Molecular medicine reports</jtitle><addtitle>Mol Med Rep</addtitle><date>2019-05-01</date><risdate>2019</risdate><volume>19</volume><issue>5</issue><spage>4057</spage><epage>4066</epage><pages>4057-4066</pages><issn>1791-2997</issn><eissn>1791-3004</eissn><abstract>Burn‑site infections, commonly due to Pseudomonas aeruginosa, have been associated with deranged intestinal integrity, allowing bacteria and their products to translocate from the gut to the circulatory system. The P. aeruginosa quorum sensing (QS) transcription factor MvfR (PqsR) controls the expression of numerous virulence factors, and the synthesis of several toxic products. However, the role of QS in intestinal integrity alterations, to the best of our knowledge, has not been previously investigated. Using a proven anti‑MvfR, anti‑virulence agent, the in vivo results of the present study revealed that inhibition of MvfR function significantly decreased Fluorescein Isothiocyanate‑Dextran (FITC‑Dextran) flow from the intestine to the systemic circulation, diminished bacterial translocation from the intestine to mesenteric lymph nodes (MLNs), and improved tight junction integrity in thermally injured and infected mice. In addition, the MvfR antagonist administration alleviates the intestinal inflammation, as demonstrated by reduced ileal TNF‑α and fecal lipocalin‑2 concentrations. In addition, it is associated with lower levels of circulating endotoxin and decreased P. aeruginosa dissemination from the burn wound to the ileum. Collectively, these results hold great promise that the inhibition of this QS system mitigates gut hyperpermeability by attenuating the derangement of morphological and immune aspects of the intestinal barrier, suggesting that MvfR function is crucial in the deterioration of intestinal integrity following P. aeruginosa burn‑site infection. Therefore, an anti‑virulence approach targeting MvfR, could potentially offer a novel therapeutic approach against multi‑drug resistant P. aeruginosa infections following thermal injuries. Since this approach is targeting virulence pathways that are non‑essential for growth or viability, our strategy is hypothesized to minimize the development of bacterial resistance, and preserve the beneficial enteric microbes, while improving intestinal integrity that is deranged as a result of burn and infection.</abstract><cop>Greece</cop><pub>Spandidos Publications</pub><pmid>30896813</pmid><doi>10.3892/mmr.2019.10071</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1791-2997
ispartof Molecular medicine reports, 2019-05, Vol.19 (5), p.4057-4066
issn 1791-2997
1791-3004
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6472113
source Spandidos Publications Journals; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects Antibiotics
Backup software
Bacteria
Burns
Circulatory system
Cytokines
Dextran
Dextrans
Digestive system
Drug resistance
Fluorescein
Fluorescein isothiocyanate
Gastrointestinal tract
Ileum
Infection
Infections
Intestine
Laboratories
Lipocalin
Lymph nodes
Lymphocytes
Microorganisms
Multidrug resistance
Novels
Permeability
Polysaccharides
Pseudomonas aeruginosa
Quorum sensing
Regulation
Sepsis
T cells
Therapeutics
Tumor necrosis factor-TNF
Tumor necrosis factor-α
Virulence factors
title Targeting bacterial quorum sensing shows promise in improving intestinal barrier function following burn‑site infection
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T06%3A22%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Targeting%20bacterial%20quorum%20sensing%20shows%20promise%20in%20improving%20intestinal%20barrier%20function%20following%20burn%E2%80%91site%20infection&rft.jtitle=Molecular%20medicine%20reports&rft.au=Adiliaghdam,%20Fatemeh&rft.date=2019-05-01&rft.volume=19&rft.issue=5&rft.spage=4057&rft.epage=4066&rft.pages=4057-4066&rft.issn=1791-2997&rft.eissn=1791-3004&rft_id=info:doi/10.3892/mmr.2019.10071&rft_dat=%3Cgale_pubme%3EA585448562%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2211282792&rft_id=info:pmid/30896813&rft_galeid=A585448562&rfr_iscdi=true